Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Paweł Żero

2PUBLICATIONS

10CO-AUTHORS

Paediatrics not elsewhere classifiedPharmaceutical delivery technologies

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Feb 27, 2023

Limited sampling strategy to predict free mycophenolic acid area under the concentration-time curve in paediatric patients with nephrotic syndrome.

Joanna Sobiak, Paweł Żero, Jacek Zachwieja

|Jun 02, 2021

Development and Bio-Predictive Evaluation of Biopharmaceutical Properties of Sustained-Release Tablets with a Novel GPR40 Agonist for a First-in-Human Clinical Trial.

Ewelina Juszczyk, Kamil Kisło, Paweł Żero

Pageof 1

Frequent Collaborators

1 joint publications

Ewelina Juszczyk

1 joint publications

Jadwiga Paszkowska

1 joint publications

Marcela Wiater

1 joint publications

Dagmara Hoc

1 joint publications

Grzegorz Garbacz

1 joint publications

Dorota Danielak

1 joint publications

Joanna Sobiak

1 joint publications

Jacek Zachwieja

1 joint publications

Danuta Ostalska-Nowicka

1 joint publications

Tomasz Pawiński

Frequent Collaborators

1 joint publications

Ewelina Juszczyk

1 joint publications

Jadwiga Paszkowska

1 joint publications

Marcela Wiater

1 joint publications

Dagmara Hoc

Top Related Videos

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on : Dec 03, 2020

See more related videos

Top Related Videos

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on : Dec 03, 2020

See more related videos